FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer - Gray, R; Morton, D; Brown, G; Ferry, DR; Magill, L; Quirke, P; Seymour, M; Warren, B; Grp, F (2010)